Global HIV / AIDS Pipeline Review 2016 - 100+ Pharma Companies & Drug Profiles - Research and Markets

DUBLIN--(BUSINESS WIRE)--Research and Markets has announced the addition of the "HIV / AIDS - Pipeline Review, H1 2016" report to their offering.

This report provides comprehensive information on the therapeutic development for HIV / AIDS, complete with comparative analysis at various stages, therapeutics assessment by drug target, mechanism of action (MoA), route of administration (RoA) and molecule type, along with latest updates, and featured news and press releases. It also reviews key players involved in the therapeutic development for HIV / AIDS and special features on late-stage and discontinued projects.

The report enhances decision making capabilities and help to create effective counter strategies to gain competitive advantage. It strengthens R&D pipelines by identifying new targets and MOAs to produce first-in-class and best-in-class products.

Key Topics Covered:

1. Introduction
2. HIV / AIDS Overview
3. Therapeutics Development
4. Pipeline Products for HIV / AIDS - Overview
5. Pipeline Products for HIV / AIDS - Comparative Analysis
6. HIV / AIDS - Therapeutics under Development by Companies
7. HIV / AIDS - Therapeutics under Investigation by Universities/Institutes
8. HIV / AIDS Products Glance
9. Late Stage Products
10. Clinical Stage Products
11. Early Stage Products
12. HIV / AIDS - Products under Development by Companies
13. HIV / AIDS - Products under Investigation by Universities/Institutes
14. HIV / AIDS - Companies Involved in Therapeutics Development

• Abivax S.A.
• AdAlta Pty Ltd.
• Advanced Genetic Systems, Inc.
• Akshaya Bio Inc.
• AlbaJuna Therapeutics
• Altor BioScience Corporation
• Altravax, Inc.
• Amarna Therapeutics B.V.
• American Gene Technologies International Inc.
• Amplyx Pharmaceuticals, Inc.
• Amunix Operating Inc.
• Antigen Express, Inc.
• Aphios Corporation
• Apotex Inc.
• Argos Therapeutics, Inc.
• Arno Therapeutics, Inc.
• Avexa Limited
• BCI Pharma
• BioClonetics Immunotherapeutics, Inc.
• Bionor Pharma ASA
• Biosantech SA
• Biotron Limited
• Boehringer Ingelheim GmbH
• C4X Discovery Holdings PLC
• CEL-SCI Corporation
• Celgene Corporation
• Celldex Therapeutics, Inc.
• Chipscreen Biosciences Ltd
• CompleGen, Inc.
• ContraVir Pharmaceuticals, Inc.
• Critical Outcome Technologies Inc.
• CureVac GmbH
• Cytodyn Inc.
• Enzo Biochem, Inc.
• EpiVax, Inc.

For more information about this report visit http://www.researchandmarkets.com/research/fnjv9v/hiv_aids

Related Topics: Immune Disorders Drugs, Infectious Diseases Drugs, HIV/AIDS Drugs